Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProbCluster
NCT07318870Phase 2Recruiting
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- Aug 2026
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of probenecid in focal epilepsy, seizure cluster, sponsored by Adolphe de Rothschild Foundation Hospital. Started Aug 2026; status: recruiting.
02
Drugs
probenecid
03
Conditions
focal epilepsyseizure cluster
Beyond the preview
Go deeper on NCT07318870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07318870.